Aulia Iskandarsyah1, Irma M Puspitasari2,3, Keri Lestari2,3. 1. Department of Clinical Psychology, Faculty of Psychology, Universitas Padjadjaran, Jatinangor-Sumedang, West Java Indonesia. 2. Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Raya Bandung Sumedang KM 21, Jatinangor, West Java 45363 Indonesia. 3. Centre of Excellence for Pharmaceutical Care Innovation, Universitas Padjadjaran, Jatinangor-Sumedang, West Java Indonesia.
Abstract
PURPOSE: The quality of life (QoL) of patients with type 2 diabetes mellitus (T2DM) is a measure of the successful outcomes of therapy. The program of management of chronic diseases "Program Pengelolaan Penyakit Kronis" (Prolanis) among patients with hypertension and T2DM is a new strategy of the Badan Penyelenggara Jaminan Sosial (BPJS), which is the Indonesian national health insurance system. Here, we analyzed the impact of pharmacist counseling interventions on health-related QoL (HRQoL) in Prolanis T2DM patients. METHODS: This cluster randomized controlled trial was designed to include two groups [control (n = 111) and intervention (n = 109) groups], and pre- and post-test procedures. The participants were Prolanis T2DM patients who attended four primary health-care centers (Puskesmas) in Makassar City, South Sulawesi, Indonesia from August 2017 to August 2018. The intervention group received systematic counseling for 6 months. The data were collected using the Bahasa Indonesia version of the European Quality of Life 5 Dimensions 5 Levels (EQ-5D-5 L) questionnaire and were analyzed using EQ-5D preference weight for each health state with the Indonesian EQ-5D-5 L value Set. Furthermore, the EQ-5D index and the EQ-5D VAS score were calculated and HbA1c levels were assessed. RESULTS: The change in the EQ-5D-5 L index score (post-pre) was 0.01 in the control group and 0.04 in the intervention group (P = 0.041). The change in the VAS score was -0.07in the control group (post-pre) and 2.66 in the intervention group (P = 0.000). CONCLUSION: Pharmacist counseling may help improve the HRQoL of Prolanis T2DM patients.
PURPOSE: The quality of life (QoL) of patients with type 2 diabetes mellitus (T2DM) is a measure of the successful outcomes of therapy. The program of management of chronic diseases "Program Pengelolaan Penyakit Kronis" (Prolanis) among patients with hypertension and T2DM is a new strategy of the Badan Penyelenggara Jaminan Sosial (BPJS), which is the Indonesian national health insurance system. Here, we analyzed the impact of pharmacist counseling interventions on health-related QoL (HRQoL) in Prolanis T2DM patients. METHODS: This cluster randomized controlled trial was designed to include two groups [control (n = 111) and intervention (n = 109) groups], and pre- and post-test procedures. The participants were Prolanis T2DM patients who attended four primary health-care centers (Puskesmas) in Makassar City, South Sulawesi, Indonesia from August 2017 to August 2018. The intervention group received systematic counseling for 6 months. The data were collected using the Bahasa Indonesia version of the European Quality of Life 5 Dimensions 5 Levels (EQ-5D-5 L) questionnaire and were analyzed using EQ-5D preference weight for each health state with the Indonesian EQ-5D-5 L value Set. Furthermore, the EQ-5D index and the EQ-5D VAS score were calculated and HbA1c levels were assessed. RESULTS: The change in the EQ-5D-5 L index score (post-pre) was 0.01 in the control group and 0.04 in the intervention group (P = 0.041). The change in the VAS score was -0.07in the control group (post-pre) and 2.66 in the intervention group (P = 0.000). CONCLUSION: Pharmacist counseling may help improve the HRQoL of Prolanis T2DM patients.
Authors: Calypse B Agborsangaya; Darren Lau; Markus Lahtinen; Tim Cooke; Jeffrey A Johnson Journal: Qual Life Res Date: 2012-06-09 Impact factor: 4.147
Authors: Carrie L Johnson; Amy Nicholas; Holly Divine; Donald G Perrier; Karen Blumenschein; Douglas T Steinke Journal: J Am Pharm Assoc (2003) Date: 2008 Nov-Dec
Authors: Fredrick Dermawan Purba; Joke A M Hunfeld; Aulia Iskandarsyah; Titi Sahidah Fitriana; Sawitri Supardi Sadarjoen; Juan Manuel Ramos-Goñi; Jan Passchier; Jan J V Busschbach Journal: Pharmacoeconomics Date: 2017-11 Impact factor: 4.981
Authors: Claire Coutureau; Florian Slimano; Céline Mongaret; Lukshe Kanagaratnam Journal: Int J Environ Res Public Health Date: 2022-03-08 Impact factor: 3.390